Dixon Hubard Feinour & Brown’s DexCom DXCM Stock Holding History

Dixon Hubard Feinour & Brown’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-24,336	Closed	-$2.51M	–	183
2020 Q4	$2.51M	Hold	24,336	–	–	0.64%	37
2020 Q3	$2.51M	Buy	24,336 +2,836	+13%	+$296K	0.64%	37
2020 Q2	$2.25M	Buy	21,500 +260	+1%	+$23.3K	0.58%	40
2020 Q1	$1.43M	Buy	+21,240	New	+$1.32M	0.48%	42

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Dixon Hubard Feinour & Brown's DXCM Position: Q1 2021 in Review

Dixon Hubard Feinour & Brown sold out of DexCom (DXCM) in Q1 2021, closing a stake of 24,336 shares — an estimated $2.51M sold.

Dixon Hubard Feinour & Brown first reported a position in DXCM in Q1 2020 and held it in 4 quarters. The position peaked at $2.51M in Q4 2020. 730 funds tracked by Wall St. Rank hold DXCM as of Q1 2021.

Dixon Hubard Feinour & Brown reported no remaining DexCom position as of Q1 2021 after selling out during the quarter.
Dixon Hubard Feinour & Brown sold 24,336 DexCom shares in Q1 2021, an estimated $2.51M.
Dixon Hubard Feinour & Brown first reported a position in DexCom in Q1 2020 and held it in 4 quarters.
Dixon Hubard Feinour & Brown's DexCom position peaked at $2.51M in Q4 2020.
730 funds tracked by Wall St. Rank held DexCom as of Q1 2021.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q1 2021, filed 11 May 2021.